xpeer logo
© Xpeer 2026 All rights reserved
Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Improving concomitant chronic venous disease (CVeD) and diabetes mellitus (DM) type 2 patient care

4.9

Accredited (Credits: 1)
Free
59min
Audio: English +1
Subtitles: Portuguese +2

Synopsis

Discover the intricate connection between chronic venous disease and diabetes mellitus type 2 in this course, led by renowned experts in the field. Explore shared risk factors and pathogenesis, empowering participants to improve diagnosis and optimize treatment for both conditions. Unravel guidelines to ensure evidence-based management. A comprehensive, concise, and essential program for healthcare professionals seeking a deeper understanding of these interlinked disorders. This activity is supported by an independent support grant from OM Pharma.

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

59min

Target audience

Vascular surgery, Endocrinology, Internal medicine, Family medicine

Authors

Prof. Dr. Armando Mansilha

Armando Mansilha, MD, PHD, FEBVS, FIUA is Professor of Vascular Surgery at the Faculty of Medicine of the University of Porto. He is also Director of the Department of Angiology and Vascular Surgery at the São João University Hospital, and fellow of the European Board of Vascular Surgery. He has published more than 400 publications in peer-review journals and books.

Conflicts of interests statement:

Armando Mansilha discloses receiving honoraria/consultation fees from OM Pharma, Servier, and Alfa Sigma.

Testimonials

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

Read more reviews onTrustpilot

FAQs

What you will learn

Introduction

  • Diabetes mellitus (DM) type 2 is an aggravating factor of chronic venous insufficiency (CVI)
  • The rationale behind optimal care for chronic venous disease (CVeD) and DM type 2 patients

Similarities between CVeD and DM type 2

  • The coexistence and link of CVeD and DM type 2
  • How can we think of CVeD and DM type 2 as one entity?

Addressing CVeD and DM type 2 as a concomitant condition in patients

  • The role of endothelial glycocalyx and enhancing the identification of both diseases
  • Optimizing the treatment and management strategies for patients with CveD and DM type 2

Addressing CVeD and DM type 2 as a concomitant condition in patients

  • A review of venoactive drugs recommendations in past guidelines
  • What do 2022 ESVS clinical practice guidelines say?

What is the place of venoactive drugs?

  • Should we treat the CVeD patient with GLP-1 agonists?
  • What is the cause behind the association of CVeD and DM type 2?
  • The evidence and importance behind endothelial glycocalyx dysfunction
  • The need for a treatment consensus for CVeD and DM

Accreditation - Evaluation

  • Satisfaction survey
  • Multiple-choice test

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account